vs

Side-by-side financial comparison of BXP, Inc. (BXP) and Enovis CORP (ENOV). Click either name above to swap in a different company.

BXP, Inc. is the larger business by last-quarter revenue ($872.1M vs $548.9M, roughly 1.6× Enovis CORP). BXP, Inc. runs the higher net margin — 15.3% vs -104.1%, a 119.3% gap on every dollar of revenue. On growth, BXP, Inc. posted the faster year-over-year revenue change (0.8% vs -2.2%). Over the past eight quarters, Enovis CORP's revenue compounded faster (9.8% CAGR vs 1.3%).

BXP Inc., operating as Boston Properties, is a leading U.S. real estate investment trust focused on owning, managing and developing high-quality Class A commercial office properties across major U.S. metro markets, serving diverse corporate, tech and professional service tenants.

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

BXP vs ENOV — Head-to-Head

Bigger by revenue
BXP
BXP
1.6× larger
BXP
$872.1M
$548.9M
ENOV
Growing faster (revenue YoY)
BXP
BXP
+3.0% gap
BXP
0.8%
-2.2%
ENOV
Higher net margin
BXP
BXP
119.3% more per $
BXP
15.3%
-104.1%
ENOV
Faster 2-yr revenue CAGR
ENOV
ENOV
Annualised
ENOV
9.8%
1.3%
BXP

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
BXP
BXP
ENOV
ENOV
Revenue
$872.1M
$548.9M
Net Profit
$133.0M
$-571.1M
Gross Margin
59.9%
Operating Margin
-101.7%
Net Margin
15.3%
-104.1%
Revenue YoY
0.8%
-2.2%
Net Profit YoY
53.0%
18.8%
EPS (diluted)
$1.69
$-9.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BXP
BXP
ENOV
ENOV
Q1 26
$872.1M
Q4 25
$877.1M
$548.9M
Q3 25
$871.5M
$564.5M
Q2 25
$868.5M
$558.8M
Q1 25
$865.2M
Q4 24
$858.6M
$561.0M
Q3 24
$859.2M
$505.2M
Q2 24
$850.5M
$525.2M
Net Profit
BXP
BXP
ENOV
ENOV
Q1 26
$133.0M
Q4 25
$248.4M
$-571.1M
Q3 25
$-121.7M
$-36.7M
Q2 25
$89.0M
$-56.0M
Q1 25
$61.2M
Q4 24
$-228.9M
$-703.2M
Q3 24
$83.6M
$-31.5M
Q2 24
$79.6M
$-18.6M
Gross Margin
BXP
BXP
ENOV
ENOV
Q1 26
Q4 25
58.8%
59.9%
Q3 25
59.3%
59.3%
Q2 25
59.2%
59.5%
Q1 25
59.2%
Q4 24
59.7%
54.8%
Q3 24
59.5%
56.7%
Q2 24
59.8%
55.0%
Operating Margin
BXP
BXP
ENOV
ENOV
Q1 26
Q4 25
-101.7%
Q3 25
-3.0%
Q2 25
-8.4%
Q1 25
Q4 24
-118.5%
Q3 24
-6.3%
Q2 24
-8.4%
Net Margin
BXP
BXP
ENOV
ENOV
Q1 26
15.3%
Q4 25
28.3%
-104.1%
Q3 25
-14.0%
-6.5%
Q2 25
10.2%
-10.0%
Q1 25
7.1%
Q4 24
-26.7%
-125.4%
Q3 24
9.7%
-6.2%
Q2 24
9.4%
-3.5%
EPS (diluted)
BXP
BXP
ENOV
ENOV
Q1 26
$1.69
Q4 25
$1.56
$-9.99
Q3 25
$-0.77
$-0.64
Q2 25
$0.56
$-0.98
Q1 25
$0.39
Q4 24
$-1.46
$-12.69
Q3 24
$0.53
$-0.58
Q2 24
$0.51
$-0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BXP
BXP
ENOV
ENOV
Cash + ST InvestmentsLiquidity on hand
$512.8M
$33.6M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$7.7B
$2.0B
Total Assets
$25.1B
$4.4B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BXP
BXP
ENOV
ENOV
Q1 26
$512.8M
Q4 25
$1.5B
$33.6M
Q3 25
$861.1M
$44.1M
Q2 25
$447.0M
$38.5M
Q1 25
$398.1M
Q4 24
$1.3B
$48.2M
Q3 24
$1.4B
$35.4M
Q2 24
$685.4M
$35.0M
Total Debt
BXP
BXP
ENOV
ENOV
Q1 26
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Stockholders' Equity
BXP
BXP
ENOV
ENOV
Q1 26
$7.7B
Q4 25
$5.1B
$2.0B
Q3 25
$5.0B
$2.6B
Q2 25
$5.3B
$2.6B
Q1 25
$5.3B
Q4 24
$5.4B
$2.6B
Q3 24
$5.8B
$3.3B
Q2 24
$5.8B
$3.3B
Total Assets
BXP
BXP
ENOV
ENOV
Q1 26
$25.1B
Q4 25
$26.2B
$4.4B
Q3 25
$26.0B
$5.0B
Q2 25
$25.6B
$4.9B
Q1 25
$25.4B
Q4 24
$26.1B
$4.7B
Q3 24
$26.4B
$5.6B
Q2 24
$25.5B
$5.4B
Debt / Equity
BXP
BXP
ENOV
ENOV
Q1 26
Q4 25
0.67×
Q3 25
0.54×
Q2 25
0.53×
Q1 25
Q4 24
0.52×
Q3 24
0.40×
Q2 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BXP
BXP
ENOV
ENOV
Operating Cash FlowLast quarter
$82.6M
Free Cash FlowOCF − Capex
$29.1M
FCF MarginFCF / Revenue
5.3%
Capex IntensityCapex / Revenue
1.5%
9.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$22.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BXP
BXP
ENOV
ENOV
Q1 26
Q4 25
$407.8M
$82.6M
Q3 25
$274.2M
$47.8M
Q2 25
$353.1M
$-1.6M
Q1 25
$210.0M
Q4 24
$383.7M
$88.3M
Q3 24
$286.1M
$53.6M
Q2 24
$367.1M
$7.8M
Free Cash Flow
BXP
BXP
ENOV
ENOV
Q1 26
Q4 25
$362.7M
$29.1M
Q3 25
$231.6M
$3.4M
Q2 25
$281.5M
$-44.9M
Q1 25
$152.6M
Q4 24
$312.5M
$35.1M
Q3 24
$234.5M
$2.4M
Q2 24
$332.4M
$-31.6M
FCF Margin
BXP
BXP
ENOV
ENOV
Q1 26
Q4 25
41.4%
5.3%
Q3 25
26.6%
0.6%
Q2 25
32.4%
-8.0%
Q1 25
17.6%
Q4 24
36.4%
6.3%
Q3 24
27.3%
0.5%
Q2 24
39.1%
-6.0%
Capex Intensity
BXP
BXP
ENOV
ENOV
Q1 26
1.5%
Q4 25
5.1%
9.7%
Q3 25
4.9%
7.9%
Q2 25
8.2%
7.7%
Q1 25
6.6%
Q4 24
8.3%
9.5%
Q3 24
6.0%
10.1%
Q2 24
4.1%
7.5%
Cash Conversion
BXP
BXP
ENOV
ENOV
Q1 26
Q4 25
1.64×
Q3 25
Q2 25
3.97×
Q1 25
3.43×
Q4 24
Q3 24
3.42×
Q2 24
4.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BXP
BXP

Lease$818.2M94%
Parking and other$30.8M4%
Development and management services$9.2M1%

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

Related Comparisons